Pharmaceuticals

Sulphonamides Market Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2019-2025

May 19, 2020 by OMRGlobal

The global sulphonamides market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Rising prevalence of infectious diseases is primarily driving the demand for sulphonamides as an antimicrobial to inhibit bacterial growth. Sulphonamides are used for the treatment of several infectious diseases including meningitis, tuberculosis, urinary tract infections (UTIs), and eye infections. Rising demand for contact lens has increased the concerns regarding eye infection. As per the American Academy of Ophthalmology, in the US, approximately one million eye infections that require a trip to the doctor or hospital happen annually, several of these infections are related to the use of contact lens.

A full report of Global Sulphonamides Market is available at:  https://www.omrglobal.com/industry-reports/sulphonamides-market

As per the Centers for Disease Control and Prevention (CDC), in the US, nearly 45 million people wear contact lenses. Wearing a contact lens is a major risk factor for microbial keratitis, a corneal infection caused by bacteria. In addition, poor hygiene is a major risk factor for several eye complications, such as microbial keratitis and another contact lens–associated inflammation. This results in the adoption of topical sulphonamides as an anti-infectives for the treatment of infections of the eye. It can be applied as an eye drop or ointment to stop bacterial growth. Doctors generally recommend to not wear contact lens while using this medication.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/sulphonamides-market

Rising prevalence of urinary tract infections is further encouraging the demand for sulphonamides. Increasing ageing population is among the major causes of UTIs among individuals. However, it can affect people of all age group. As per the World Health Organization (WHO), urinary tract infection (UTI) is the major cause of morbidity and healthcare spending among all age group individuals. An estimated 40%-50% of women witnessed having UTI at some point in their lives. This increases the demand for antimicrobials for the treatment of UTIs.

Sulfonamides act to restrict bacterial dihydropteroate synthase by competing with para-aminobenzoic acid (PABA). It interferes with the uptake of PABA into folic acid, which is an important component for the development of bacteria. Trimethoprim-sulfamethoxazole (TMP-SMX) can be recommended by the doctors to take the benefit of the synergy between trimethoprim and sulfonamides. The activity of TMP-SMX comprises common urinary tract pathogens, both aerobic gram-negative and gram-positive bacteria, except Pseudomonas aeruginosa. Therefore, the rising prevalence of infectious diseases has led to the global sulphonamides market.

Global Sulphonamides Market- Segmentation

By Route of Administration
  • Oral
  • Topical
By Application
  • Urinary Tract Infection
  • Skin Infection
  • Eye Infection
  • Respiratory Tract Infection
  • Gastrointestinal Tract Infection
  • Others
For more customized data, request for report customization @  https://www.omrglobal.com/report-customization/sulphonamides-market

Global Sulphonamides Market– Segment by Region

North America          
  • United States
  • Canada
Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific   
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
Rest of the World
  • Middle East & Africa
  • Latin America
Company Profiles
  • AA Pharma Inc.
  • Abbott Laboratories
  • Allergan plc
  • Bausch Health Companies Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • DK Pharmachem Pvt. Ltd.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Lexine Technochem Pvt. Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • Prudence Pharma Chem
  • Teva Pharmaceutical Industries Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research


Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404
0 Comments

0 Comments

Post a Comment